Siponimod (BAF312) for the Treatment of Secondary Progressive Multiple Sclerosis: Design of the Phase 3 EXPAND Trial Kappos L, Bar-Or A, Cree B, Fox R, Giovannoni G, Gold R, Vermersch P, Lam E, Pohlmann H, Zhang-Auberson L, et al., Neurology (Meeting Abstracts), 12 Feb 2013 Accessed on 11 Aug 2013 from http://www.neurology.org/cgi/content/meeting_abstract/80/1_MeetingAbstracts/P07.126. CommentRecommendBookmarkWatch